DK0708648T3 - Hæmning af nitrogenoxidproduktion med retinsyre - Google Patents

Hæmning af nitrogenoxidproduktion med retinsyre

Info

Publication number
DK0708648T3
DK0708648T3 DK94917915T DK94917915T DK0708648T3 DK 0708648 T3 DK0708648 T3 DK 0708648T3 DK 94917915 T DK94917915 T DK 94917915T DK 94917915 T DK94917915 T DK 94917915T DK 0708648 T3 DK0708648 T3 DK 0708648T3
Authority
DK
Denmark
Prior art keywords
retinoic acid
nitric oxide
inhibition
oxide production
production
Prior art date
Application number
DK94917915T
Other languages
English (en)
Inventor
Bharat B Aggarwal
Kapil Mehta
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Application granted granted Critical
Publication of DK0708648T3 publication Critical patent/DK0708648T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK94917915T 1993-05-17 1994-05-05 Hæmning af nitrogenoxidproduktion med retinsyre DK0708648T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/061,471 US5457129A (en) 1993-05-17 1993-05-17 Inhibition of nitric oxide production by retinoic acid
PCT/US1994/004950 WO1994026277A1 (en) 1993-05-17 1994-05-05 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid

Publications (1)

Publication Number Publication Date
DK0708648T3 true DK0708648T3 (da) 2003-03-03

Family

ID=22036008

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94917915T DK0708648T3 (da) 1993-05-17 1994-05-05 Hæmning af nitrogenoxidproduktion med retinsyre

Country Status (17)

Country Link
US (2) US5457129A (da)
EP (2) EP0708648B1 (da)
JP (2) JPH08510727A (da)
KR (1) KR100345255B1 (da)
AT (1) ATE228363T1 (da)
AU (1) AU697072B2 (da)
CA (1) CA2162990A1 (da)
DE (1) DE69431801T2 (da)
DK (1) DK0708648T3 (da)
ES (1) ES2187522T3 (da)
IL (1) IL109458A (da)
NZ (1) NZ267220A (da)
PT (1) PT708648E (da)
SA (1) SA94150042B1 (da)
TW (1) TW261529B (da)
WO (1) WO1994026277A1 (da)
ZA (1) ZA943320B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786332A (en) * 1995-03-06 1998-07-28 Trega Biosciences, Inc. Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels
US5741774A (en) * 1993-11-12 1998-04-21 Trega Biosciences, Inc. Use of a cytokine regulatory agent to treat rheumatoid arthritis
FR2735371B1 (fr) * 1995-06-19 1997-07-18 Cird Galderma Procede pour identifier des composes antagonistes des recepteurs rars
FR2767058B1 (fr) * 1997-08-05 2000-05-05 Centre Nat Rech Scient Utilisation d'un compose de type retinoide, notamment l'acide retinoique pour la preparation d' un medicament destine au traitement de l'obesite.
US8541469B2 (en) * 1997-08-23 2013-09-24 Glaxo Group Limited Treatment of cell-mediated immune diseases
EP0908179A1 (en) * 1997-08-23 1999-04-14 Werner Bollag Treatment of cell-mediated immune diseases
EP1016719A4 (en) * 1997-09-02 2000-12-13 Sumitomo Pharma DNA PARTICIPATING IN THE REGULATION OF THE EXPRESSION OF THE PEBP2 A GENE AND THE USE THEREOF
US6596500B1 (en) * 1998-12-08 2003-07-22 The General Hospital Corporation Binding of retinoids to M6P/IGF-II receptor
US6242473B1 (en) * 1999-01-08 2001-06-05 Maxim Pharmaceuticals, Inc. Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
US6184246B1 (en) 1999-07-30 2001-02-06 The United States Of America As Represented By The Secretary Of Agriculture Inhibition of cytokine production by polymethoxylated flavones
WO2001028533A2 (en) * 1999-10-19 2001-04-26 Kain Kevin C PRODUCTS AND METHODS FOR ACTIVATING PPARη-RXR AND UP-REGULATING MONOCYTE/MACROPHAGE CD36 FOR THE TREATMENT OF MALARIA
CA2435410A1 (en) * 2001-01-26 2002-08-01 Steven Baranowitz Systemic formulations containing beta-carotene and derivatives thereof
JP2004020220A (ja) * 2002-06-12 2004-01-22 Pioneer Electronic Corp 通信システム及び方法、通信端末装置、通信センタ装置、並びにコンピュータプログラム
US7071228B2 (en) * 2002-10-23 2006-07-04 Parks L Dean Method of treating musculoskeletal and connective tissue inflammations
WO2006088747A2 (en) * 2005-02-14 2006-08-24 Mercer University Serum-free reagents for the isolation, cultivation, and cryopreservation of postnatal pluripotent epiblast-like stem cells
WO2007000939A1 (ja) * 2005-06-28 2007-01-04 St. Marianna University, School Of Medicine 局所炎症治療用薬剤
WO2007104030A1 (en) * 2006-03-08 2007-09-13 Kinemed, Inc. Retinoids and related compounds for the treatment of neuroinflammatory conditions, diseases and disorders
WO2011038537A1 (zh) * 2009-09-29 2011-04-07 上海南方基因科技有限公司 败血症以及败血症休克的预测、预防和治疗方法及试剂盒

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200647A (en) * 1977-12-21 1980-04-29 Hoffmann-La Roche Inc. Vitamin A compositions to treat rheumatic disease
EP0071357B1 (en) * 1981-07-14 1985-01-02 Efamol Limited Pharmaceutical and dietary composition when used for enhancement of 1-series pg production
US5264578A (en) * 1987-03-20 1993-11-23 Allergan, Inc. Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
WO1989006977A1 (en) * 1988-02-04 1989-08-10 Board Of Regents, The University Of Texas System Formulation and use of retinoids in treatment of cancer and other diseases
US5157046A (en) * 1988-11-29 1992-10-20 Janssen Pharmaceutica N.V. Method of treating epithelial disorders
US5190876A (en) * 1988-12-27 1993-03-02 Emory University Method of modifying cellular differentiation and function and compositions therefor
JPH051100A (ja) * 1990-07-11 1993-01-08 Teijin Ltd 腫瘍壊死因子活性抑制物質及びその製造方法
GB9028123D0 (en) * 1990-12-28 1991-02-13 Erba Carlo Spa Monoclonal antibodies against human tumor necrosis factor alpha
ES2145744T5 (es) * 1991-01-18 2008-02-01 Amgen Inc. Procedimientos para tratar las enfermedades inducidas por el factor de necrosis tumoral.
US5795859A (en) * 1991-07-05 1998-08-18 Peptide Technology Limited Peptide which abrogates TNF and/or LPS toxicity
AU3659293A (en) * 1992-02-11 1993-09-03 Allergan, Inc. Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity

Also Published As

Publication number Publication date
DE69431801D1 (de) 2003-01-09
US5658949A (en) 1997-08-19
IL109458A (en) 2001-11-25
EP0708648A1 (en) 1996-05-01
JP2005263808A (ja) 2005-09-29
KR960702311A (ko) 1996-04-27
NZ267220A (en) 2000-08-25
EP0708648B1 (en) 2002-11-27
WO1994026277A1 (en) 1994-11-24
SA94150042B1 (ar) 2006-06-17
KR100345255B1 (ko) 2002-11-30
IL109458A0 (en) 1994-07-31
AU697072B2 (en) 1998-09-24
PT708648E (pt) 2003-04-30
TW261529B (da) 1995-11-01
CA2162990A1 (en) 1994-11-24
US5457129A (en) 1995-10-10
ZA943320B (en) 1995-11-16
ES2187522T3 (es) 2003-06-16
EP1243264A3 (en) 2002-11-06
AU6944194A (en) 1994-12-12
EP0708648A4 (en) 1998-01-14
ATE228363T1 (de) 2002-12-15
DE69431801T2 (de) 2003-09-11
EP1243264A2 (en) 2002-09-25
JPH08510727A (ja) 1996-11-12

Similar Documents

Publication Publication Date Title
DK0708648T3 (da) Hæmning af nitrogenoxidproduktion med retinsyre
ATE157152T1 (de) Wiederherstellung des betriebszustandes eines bereichsgetriebes nach einer getriebestrangunterbrechung
DE69303935D1 (de) Verfahren zur Herstellung von 4-Bromomethylbiphenyl-Verbindungen
ATE283542T1 (de) Mikrosolenoidspule und verfahren zu ihrer herstellung
JPS5779922A (en) Automatic focusing camera
JPS52144614A (en) Polyprenyl carboxylic acid compounds and hypo-tensor containing same
ITMI910380A1 (it) Composti steroidei attivi sul sistema cardiovascolare
FR2705511B1 (fr) Procédé de commande d'un circuit électronique par un courant de polarisation et circuit électronique mettant en Óoeuvre le procédé.
DK73389A (da) Fremgangsmaade til deacylering af forbindelser omfattende to aromatiske kerner
ITMI920329A1 (it) Polimeri conduttori a conducibilita' ionica
ATE213563T1 (de) Temperatur-stabilisierter dauermagnet
ATE162660T1 (de) Vorrichtung zur aufbewahrung von magnetbandkassetten
JPS5357246A (en) Polyethylene resin compositions having improved adhesivity
JPS52138922A (en) Lens system
FR2687403B1 (fr) Procede de fabrication d'un ester d'un compose organosilane et utilisation.
DK0599789T3 (da) Rulle af selvklæbende tape fremstillet af plast eller tilsvarende film, opviklet på en rørformet kerne med reduceret diameter
FR2690288B1 (fr) Limiteur de courant supraconducteur a haute tension.
JPS6455882A (en) Stabilizing circuit for output of semiconductor laser light
JPS5718613A (en) Cholagogue
DK0442411T3 (da) Konisk fjeder til elektrisk kontaktdannelse
JPS5442109A (en) Motor control circuit of magnetic recorder-reproducer
JPS5324262A (en) Objective lens for electronic microscope
ATE106489T1 (de) Eckenschutz für wände, träger, stützen etc.
KR910017556A (ko) 저온 산화막의 슬로프 에치방법
DK549789A (da) Fremgangsmaade til fremstilling af optisk aktive acyloxyazetidinoner